Gustavo Jimenez-Maggiora, PhD, MBA
Biography
Gustavo A. Jimenez-Maggiora, PhD, MBA, is the Director of the Informatics Section at the USC Alzheimer’s Therapeutic Research Institute (ATRI), Keck School of Medicine of USC. An accomplished informatician specializing in neurology and neurodegenerative diseases, he leverages his extensive experience and expertise to lead ATRI’s data management, informatics, and information technology teams, advancing the institute’s mission and research programs.
Dr. Jimenez-Maggiora directs the Informatics Unit for the Alzheimer’s Clinical Trials Consortium (ACTC) and spearheads the development of the ACTC Informatics Platform (ACTC-IP). This platform supports the ACTC program and its scientific goals by providing a robust, secure, and scalable infrastructure for information management, collaboration, and process management. The ACTC-IP enhances research management and coordination by facilitating the collection, cleaning, storage, processing, analysis, visualization, auditing, and dissemination of scientific, operational, and administrative data using standardized data models, formats, and taxonomies. Its capabilities support various research processes, including digital recruitment and retention, trial data collection and query management, neuroimaging acquisition and data management, safety monitoring, laboratory information management, research administration, and data sharing.
In addition to his directorial role, Dr. Jimenez-Maggiora is a co-investigator on multiple national and international programs. He serves as the informatics lead for the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Clinical Core, the informatics co-lead for the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), and the Informatics Core co-lead for the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS). He is also the lead informatician for the Alzheimer’s Prevention Trials (APT Webstudy), the Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD), the Alzheimer Biomarkers Consortium – Down Syndrome (ABC-DS), and the Trial-Ready Cohort-Down Syndrome (TRC-DS).
As an educator, Dr. Jimenez-Maggior serves as a faculty member for the Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD) and as a senior mentor for the ATRI Student Summer Research Program. He is also a past Chair of the Society for Clinical Trials’ Education Committee.
Dr. Jimenez-Maggiora’s research interests include clinical research informatics, remote data capture systems, open science, and natural language processing, reflecting his commitment to advancing biomedical informatics and improving outcomes in Alzheimer’s disease and related dementias research.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Your Title Goes Here
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.